|
THE DIRECT CLIENT BUSINESS AUDIT Most translators who say they want direct clients don’t have a pipeline problem. They have a positioning problem they haven’t diagnosed yet. The difference matters. A pipeline problem is fixable with outreach. A positioning problem means the outreach you’re doing won’t work - not because you’re doing it wrong, but because there’s nothing positioned behind it for a direct client to buy into. This audit won’t flatter you. It’s designed to tell you where you actually stand. Now score yourself 0–2 on each of the following: 0 = this doesn’t describe me at all 1 = partially true, or true in theory 2 = clearly and consistently true
Your score: 8–10 - You’re already positioned for direct clients. The question is whether you’re moving fast enough. 5–7 - You’re in transition. Some of the foundation is there; some isn’t. The gaps are worth naming specifically, because they’re the friction points slowing your growth. 0–4 - You’re not yet positioned for direct clients, and outreach alone won’t fix that. Start with the sentence in question one. Everything else follows from there. The audit doesn’t tell you how to fix what you find. That’s a lengthier conversation. But most translators skip the audit entirely. They go straight to the tactics - the LinkedIn post, the cold e-mail, the rate increase - without knowing whether the positioning underneath can stand the weight of those moves. The score is just data. What you do with it is the real question.
for the fourth week of May 2026 Over 20 translators walked into a webinar on Tuesday. They didn't come for theory. They came because they'd heard linguistic validation was one of the last strongholds areas AI genuinely can't touch - and they wanted to know if that was true, and how to get in. Module 1 covered where LV actually sits in the clinical trial process - not as a translation service, but as a regulatory compliance function. That reframe alone changes how you position yourself to a CRO. The room asked good questions. Hard ones even. How do you cite FDA PRO Guidance in a client proposal without sounding like you're bluffing? What makes cognitive debriefing something a qualified translator does - rather than something a research agency outsources at the lowest common denominator? Why do pharmaceutical clients pay Tier 1 rates for LV when they'll push back on every other line in a quote? The answer to all three is the same thing: stakes. PRO instrument validation requires cognitive debriefing with real patients, regulatory documentation and clinical judgment. That's not a workflow you can automate, simplify or prompt your way through willy nilly. The risk of getting it wrong doesn't disappear because the process looks routine from the outside. That's why the rates hold water. And that's why positioning yourself as the specialist - not the supplier - changes the entire conversation. Sessions 2 and 3 take this further: the full LV workflow in detail, and cognitive debriefing from the inside - patient in the field interviews, documentation and how to present yourself as the undisputed lead on a project. Stay tuned for the next session 25 June, 17h CET. Webinars in grateful partnership with Wordscope. I was also delighted to speak to the Israel Translators Association (ITA) this week for the second year running My talk was Linguistic Validation as a New AI-Proof Niche for Translators. I'd given versions of this content before - to different audiences, in different rooms - but something shifted in this one. About halfway through, I watched the conversation change. Not the one I was having with the room. The one happening inside the room. The moment it shifted was this: I stopped talking about what linguistic validation is and started talking about what a CRO actually buys when they hire an LV specialist. Not translation. Not even accuracy. They buy regulatory confidence. They buy the certainty that a Phase III submission won't stall because a patient-facing instrument failed cognitive debriefing review. That's not a service. That's an outcome. And outcomes are priced differently. You could see it land hard. The questions that followed weren't about rates or word counts. They were about how to frame a proposal. How to position yourself in a conversation with a clinical trial PM. Whether you could cite FDA PRO Guidance 2009 before you'd done your first LV project - and how to do it without bluffing. Those are consultant questions. Not time for money questions. That's the mindset shift I've been trying to describe ever since I began this weekly newsletter. It doesn't happen just because you read about it. It happens in a room, when the reframe becomes visceral - when you hear yourself asking a different kind of question and realise the identity underneath it has already changed. The ITA audience got there faster than most. Which tells me the niche is oven ready. The question is whether you are. 🔥Whenever you’re ready, here are a few ways I can help you:Work with me 1:1 – Mentoring spots for Q3 2026 are now open. Join the waitlist. Tune into the podcast – Every week, freelancers learn how to land premium clients and build an authority-based business. Subscribe on your favourite podcast player. To your online success, Jason Willis-Lee Founder, The Entrepreneurial Translator Forwarded this email? Sign up here |
The Entrepreneurial Translator is for freelance translators, editors and copy editors who want to future-proof their business. Expect weekly tips on finding direct clients, using AI tools smartly and building sustainable income—without overwhelm or fluff.
The best translators I know are never available. Not because they're lazy. Not because they've retired. Because they're booked out. A client emails. Can you take this on Monday? And the answer isn't yes. The answer is: I can fit you in from the 15th - or I'll add you to the waitlist if something opens sooner. Watch what happens next. The client doesn't walk away. They wait. Here's the thing nobody tells you about direct-client work: availability is not a selling point. It's the opposite. The...
You want to know why the best clinical translators I know are also the hardest to book. Not the busiest. The hardest. There's a stark difference. I had a coaching call last week with a translator who specialises in oncology PRO instruments. She turns down four projects for every one she accepts. Her rate hasn't moved in two years - because she hasn't had to move it. Client queue like a busy ice cream van on a sweltering summer afternoon. That shouldn't work, I thought the first time I saw...
A PM at a CRO you've pitched three times just installed a browser extension. She highlights your last email, right-clicks, and gets a verdict in two seconds: AI-assisted. She doesn't say anything. She just quietly moves your reply to the bottom of the pile. This isn't hypothetical any more. Pangram, the detection tool built by ex-Google engineers, now lives inside Chrome. It scans LinkedIn, Substack, Reddit, Google Docs - and it doesn't stop at obvious tells like em dashes or "it's not X,...